Events Calendar
In This Section
Can DNA tests free ex-Akron captain?
Victim of beating in Kent last week is declared dead at Akron hospital
Green High senior goes extra mile for those who walk and jog the park trails
Community, school and military news roundup
Tragedy to hope: Family creates foundation for bereavement therapy
Visiting new Navy ship brings back memories for Doylestown man serves on USS New York in 1930s
Most Read Stories
Police accuse bank robbery suspect of gobbling up note (with dashcam video)
Victim of beating in Kent last week is declared dead at Akron hospital
Dad accused of forcing son into field, killing him
Man found dead in North Akron home is identified
Can DNA tests free ex-Akron captain?
Browns' roster nearly devoid of consistent players
Coventry man killed in crash at I-77 ramp
College student mistaken for deer, shot to death
Does it work? Test team returns to try out new products advertised on television
Blogs:
Pets:
Cat-loving chihuahua suckles seven abandoned kittens
The Heldenfiles:
Friday Night Notebook
Patrick McManamon:
Browns vs. Lions live …
Akron Zips:
Hitchens leads Zips in second-half comeback
Tribe Matters:
Seven players added to Tribe’s 40-man roster
Cleveland Browns:
Robiskie, Harrison inactive
Kent State Sports:
Kent State blown out in second half, loses to Temple 47-13
Cleveland Cavaliers:
Gameblog: Cavs vs. Philadelphia 76ers
Buckeye Blogging:
OSU – Michigan college football rivals meet in Baghdad
Varsity Letters:
Four area football teams play tonight
All Da King's Men:
The Sunday Sanity Challenge
Blog of Mass Destruction:
Will Health Care Reform Pass?
Akron Law Café:
Health Care Financing Reform: (69) The Brookings Institute Study on "Bending the Curve" – Four General Strategies
See Jane Style:
Vintage Chic
Car Chase:
TIME TO GET YOUR COLLECTOR CARS WINTERIZED
Let's Talk Real Estate:
Silverdome Potentially SOLD!
Ohio Travels with Betty:
George is looking for a Thanksgiving buffet in Akron.
Sound Check:
Steely Dan Plays "The Royal Scam" at E.J. Thomas Hall
HRLite House:
A Random Rant on Testing
Akron Gamer:
Nintendo's Mario endures even as games come and go
Published on Sunday, Apr 06, 2008
Q: Have embryonic stem cells been used to treat human disease?
A: No. In fact, embryonic stem-cell research has not yet moved beyond rodents. Embryonic stem cells have not been used in any human clinical trial in the United States.
Q: Have adult stem cells been used to treat human disease?
A: Yes. Stem cells harvested from bone marrow have been used to treat leukemia and other blood cancers for over three decades.
Q: Are adult stem cells showing promise in treating other diseases?
A: Yes, though most of the research is still in very early stages. Clinical trials in humans and animals have shown positive results in repairing damaged hearts, in developing insulin-producing cells for diabetes, in producing dopamine-producing cells in Parkinson's patients, in taming autoimmune disorders, in modifying genes to reduce side effects of chemotherapy and in regenerating bone, muscle, skin and organs. Stem cells from umbilical cord blood have been used to treat leukemia, other blood cancers and some blood disorders, like sickle cell anemia, while also showing promise in treating diabetes, heart disease, autoimmune diseases and cerebral palsy.
Q: So why not rely solely on adult stem cells for research and forget about embryonic stem cells?
A: Scientists believe that embryonic stem cells have a greater potential than adult stem cells because they more easily grow into any cell type. While adult stem cells can give rise to many different cell types, no adult stem cell has been found that can give rise to all cell and tissue types. Adult stem cells are present in small quantities, which makes them difficult to isolate and purify. And adult stem cells may contain more abnormalities, caused by sunlight, toxins and errors in making copies during the course of a lifetime. Still, one major drawback of embryonic stem cells is that scientists have been unable to control the type of tissue they form or how fast they grow. If stem-cell growth can't be controlled, it will result in a tumor.
SOURCES: The National Institutes of Health,
the National Center for Regenerative
Medicine
Q: Have embryonic stem cells been used to treat human disease?
A: No. In fact, embryonic stem-cell research has not yet moved beyond rodents. Embryonic stem cells have not been used in any human clinical trial in the United States.
Q: Have adult stem cells been used to treat human disease?
A: Yes. Stem cells harvested from bone marrow have been used to treat leukemia and other blood cancers for over three decades.
Q: Are adult stem cells showing promise in treating other diseases?
A: Yes, though most of the research is still in very early stages. Clinical trials in humans and animals have shown positive results in repairing damaged hearts, in developing insulin-producing cells for diabetes, in producing dopamine-producing cells in Parkinson's patients, in taming autoimmune disorders, in modifying genes to reduce side effects of chemotherapy and in regenerating bone, muscle, skin and organs. Stem cells from umbilical cord blood have been used to treat leukemia, other blood cancers and some blood disorders, like sickle cell anemia, while also showing promise in treating diabetes, heart disease, autoimmune diseases and cerebral palsy.
Q: So why not rely solely on adult stem cells for research and forget about embryonic stem cells?
A: Scientists believe that embryonic stem cells have a greater potential than adult stem cells because they more easily grow into any cell type. While adult stem cells can give rise to many different cell types, no adult stem cell has been found that can give rise to all cell and tissue types. Adult stem cells are present in small quantities, which makes them difficult to isolate and purify. And adult stem cells may contain more abnormalities, caused by sunlight, toxins and errors in making copies during the course of a lifetime. Still, one major drawback of embryonic stem cells is that scientists have been unable to control the type of tissue they form or how fast they grow. If stem-cell growth can't be controlled, it will result in a tumor.
SOURCES: The National Institutes of Health,
the National Center for Regenerative
Medicine
Get the full article here.
